|
1
|
Vlahovic TC: Onychomycosis: Evaluation,
treatment options, managing recurrence, and patient outcomes. Clin
Podiatr Med Surg. 33:305–318. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gupta AK, Stec N, Summerbell RC, Shear NH,
Piguet V, Tosti A and Piraccini BM: Onychomycosis: A review. J Eur
Acad Dermatol Venereol. 34:1972–1990. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hombach S and Kretz M: Non-coding RNAs:
Classification, biology and functioning. Adv Exp Med Biol.
937:3–17. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lu TX and Rothenberg ME: Diagnostic,
functional, and therapeutic roles of microRNA in allergic diseases.
J Allergy Clin Immunol. 132:3–13. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Miranda KC, Bond DT, McKee M, Skog J,
Paunescu TG, Da Silva N, Brown D and Russo LM: Nucleic acids within
urinary exosomes/microvesicles are potential biomarkers for renal
disease. Kidney Int. 78:191–199. 2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mendt M, Kamerkar S, Sugimoto H, McAndrews
KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, et al:
Generation and testing of clinical-grade exosomes for pancreatic
cancer. JCI Insight. 3(e99263)2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang J, Chen J and Sen S: MicroRNA as
Biomarkers and Diagnostics. J Cell Physiol. 231:25–30.
2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Leng N, Dawson JA, Thomson JA, Ruotti V,
Rissman AI, Smits BM, Haag JD, Gould MN, Stewart RM and Kendziorski
C: EBSeq: An empirical Bayes hierarchical model for inference in
RNA-seq experiments. Bioinformatics. 29:1035–1043. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kruger J and Rehmsmeier M: RNAhybrid:
MicroRNA target prediction easy, fast and flexible. Nucleic Acids
Res. 34:W451–W454. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rozalski M, Rudnicka L and Samochocki Z:
MiRNA in atopic dermatitis. Postepy Dermatol Alergol. 33:157–162.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu WB, Jiang XF and Chen MQ: microRNA-1-3p
and T-synthase mRNA have high diagnostic efficacy on intestinal
mucosal barrier dysfunction in patients with severe acute
pancreatitis. Kaohsiung J Med Sci. 39:732–739. 2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chen Y, Liu M, Jin H, Peng B, Dai L, Wang
S, Xing H, Wang B and Wu Z: Synthetic evaluation of MicroRNA-1-3p
expression in head and neck squamous cell carcinoma based on
microarray chips and MicroRNA Sequencing. Biomed Res Int.
2021(6529255)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tao S, Li H, Ma X, Ma Y, He J, Gao Y and
Li J: Elevating microRNA-1-3p shuttled by cancer-associated
fibroblasts-derived extracellular vesicles suppresses breast cancer
progression and metastasis by inhibiting GLIS1. Cancer Gene Ther.
28:634–648. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lin Q: MicroRNA-1-3p affects lung
adenocarcinoma progression through E2F8 and regulating NF-кB
pathwayy. Cytokine. 156(155922)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhou H, Tang H, Li N, Chen H, Chen X, Gu
L, Zhang L, Tian G and Tao D: MicroRNA-361-3p inhibit the
progression of lymphoma by the Wnt/β-catenin signaling pathway.
Cancer Manag Res. 12:12375–12384. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Li J, Yang P, Chen F, Tan Y, Huang C, Shen
H, Peng C, Feng Y and Sun Y: Hypoxic colorectal cancer-derived
extracellular vesicles deliver microRNA-361-3p to facilitate cell
proliferation by targeting TRAF3 via the noncanonical NF-κB
pathways. Clin Transl Med. 11(e349)2021.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Hua B, Li Y, Yang X, Niu X, Zhao Y and Zhu
X: MicroRNA-361-3p promotes human breast cancer cell viability by
inhibiting the E2F1/P73 signalling pathway. Biomed Pharmacother.
125(109994)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ogawa H, Nakashiro KI, Tokuzen N,
Kuribayashi N, Goda H and Uchida D: MicroRNA-361-3p is a potent
therapeutic target for oral squamous cell carcinoma. Cancer Sci.
111:1645–1651. 2020.PubMed/NCBI View Article : Google Scholar
|
